The National Medical Products Administration held a symposium on drug information traceability work

Wallstreetcn
2026.01.26 12:13

The meeting listened to the recent progress of drug information traceability work and proposed requirements for accelerating the traceability of all varieties and the entire chain. The meeting emphasized that all relevant parties should expedite their work and fulfill their responsibilities. The production sector should actively study and promote the coding of all varieties, while the operation and usage sectors should standardize and timely scan codes. The drug traceability system operation units must ensure data security and improve system construction and operational management. Drug regulatory departments should strengthen policy guidance, effectively utilize trigger-based traceability scenarios, and support the "Clear Source" consolidation and enhancement action